The statistical analysis of the collected data aims to reveal the many factors that influence patient involvement in clinical trials. Findings will be disseminated through conferences and scholarly papers to benefit all parties participating in clinical trials.

These findings will help to shape the design of future clinical trials for people with tardive dyskinesia, as well as enhance recruiting techniques and retention rates.

Inclusion Criteria:

• Diagnosis of tardive dyskinesia
• Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
• No prior treatment for tardive dyskinesia

Exclusion Criteria:

• Enrolled in another research study
• Inability to provide written informed consent
• Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial

Tardive dyskinesia patients who are actively considering enrolling in a clinical trial for the said condition, but have not yet completed enrollment and randomization phases.